A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

Stephen Freedland, MD, of Cedars-Sinai, discussed enzalutamide and leuprolide's potential to improve overall survival without ...

Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

With the backing of Rishi Sunak, Prostate Cancer UK published a report to the national screening committee back in 2022 in ...

Millions of men could benefit from a new, faster prostate cancer scan. The quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer in clinical trials as the current 30- to ...

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...

Imaging has an established role in the local and distant staging of prostate cancer. However, it is increasingly demonstrating the ability to identify focal areas of tumor within the prostate gland, ...